Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lucid Diagnostics Inc
(NQ:
LUCD
)
0.8350
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lucid Diagnostics Inc
< Previous
1
2
3
Next >
LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q2 2024
August 12, 2024
LUCD stock results show that Lucid Diagnostics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
3 Hypergrowth Stocks That Speculators Should Keep Tabs On
July 29, 2024
While a high-risk proposition, these hypergrowth stocks can potentially bring enormous returns in a short period of time.
Via
InvestorPlace
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for May 2024
May 20, 2024
Although the concept of penny stocks to buy is extremely risky, these ideas have the advantage of analysts’ positive assessments.
Via
InvestorPlace
LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q1 2024
May 13, 2024
LUCD stock results show that Lucid Diagnostics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 30, 2024
Via
Benzinga
Earnings Preview: Lucid Diagnostics
March 22, 2024
Via
Benzinga
Earnings Preview For Lucid Diagnostics
November 10, 2023
Via
Benzinga
Where Lucid Diagnostics Stands With Analysts
May 17, 2023
Via
Benzinga
Preview: Lucid Diagnostics's Earnings
May 12, 2023
Via
Benzinga
Lucid Diagnostics Earnings Perspective: Return On Capital Employed
March 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
April 29, 2024
Via
Benzinga
3 Penny Stocks That Could Make a Big Comeback by the End of Q2
April 19, 2024
Although penny stocks to rebound represent one of the riskiest market categories, there could be some substance here.
Via
InvestorPlace
LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q4 2023
March 25, 2024
LUCD stock results show that Lucid Diagnostics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For March 25, 2024
March 25, 2024
Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on revenue of $161.50 million.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 19, 2024
Via
Benzinga
A Preview Of Lucid Diagnostics's Earnings
March 13, 2023
Via
Benzinga
PAVmed, Lucid Diagnostics Pause Some Development Programs, Announce Layoffs
January 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 24, 2023
Via
Benzinga
Why PAVmed Shares Are Falling Today
January 18, 2023
PAVmed Inc. (NASDAQ: PAVM) shares are trading lower after the company announced a workforce reduction of roughly 20% alongside other cost-cutting measures.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 17, 2023
Via
Benzinga
PAVmed and Lucid Diagnostics Provide Strategic Business Update
January 17, 2023
From
PAVmed Inc.
Via
Business Wire
Earnings Scheduled For November 13, 2023
November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
Via
Benzinga
Earnings Scheduled For August 14, 2023
August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
Via
Benzinga
PAVmed and Lucid Diagnostics to Provide Strategic Business Update
January 11, 2023
From
PAVmed Inc.
Via
Business Wire
PAVmed Partners with Novosound on Ultrasound Imaging Technology
December 22, 2022
From
PAVmed Inc.
Via
Business Wire
PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform
December 15, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry
December 08, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research
December 01, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Provides Business Update and Third Quarter 2022 Financial Results
November 15, 2022
From
PAVmed Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.